#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Partial seizures

Not yet recruiting

Investigational

Safety and tolerability of OV329 as add‑on therapy in adults with drug‑resistant focal epilepsy

Investigational

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Hepatic cirrhosis

Not yet recruiting

Registered drugNo placebo

Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Investigational

ELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition

Investigational

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Pancreatic carcinoma

Not yet recruiting

InvestigationalNo placebo

Phase II/III trial of autologous dendritic cells loaded with allogenic mesothelioma lysate in patients with borderline resectable pancreatic cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES

Contact Research Centre

Attention deficit hyperactivity disorder

Not yet recruiting

Investigational

Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

Investigational

The Netherlands

Participants:18–64 years
Substances:LYSERGIDE

Contact Research Centre

Lung neoplasm malignant

Not yet recruiting

Registered drugNo placebo

Study of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Febuxostat

Contact Research Centre

Glioblastoma

Not yet recruiting

Registered drugNo placebo

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Cerebral palsy

Not yet recruiting

Registered drugNo placebo

Comparison of intrathecal baclofen pump and selective dorsal rhizotomy for children with cerebral palsy who cannot walk

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Baclofen

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

A study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Acquired ATTR amyloidosis

Not yet recruiting

InvestigationalNo placebo

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acoramidis Hydrochloride

Contact Research Centre

Major depression

Not yet recruiting

Investigational

Study on the Effects of D-Cycloserine and Brain Stimulation for Patients with Major Depressive Disorder

Investigational

The Netherlands

Participants:18–64 years

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drugNo placebo

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.